Related Experiment Videos
Diabetic CVD--soluble epoxide hydrolase as a target
Aurelien Lorthioir1, Dominique Guerrot, Robinson Joannides
1Department of Pharmacology, Rouen University Hospital, Rouen, France.
Summary
Diabetic cardiovascular disease is common. Restoring epoxyeicosatrienoic acids (EETs) bioavailability may prevent complications by improving endothelial function, offering a promising therapeutic strategy.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Cardiovascular diseases (CVD) are prevalent in diabetic patients despite optimized glucose control.
- Endothelial dysfunction, linked to reduced epoxyeicosatrienoic acids (EETs) bioavailability, contributes to diabetic complications.
Purpose of the Study:
- To review the role of the EET pathway in diabetic cardiovascular complications.
- To analyze the therapeutic potential of soluble epoxide hydrolase (sEH) inhibitors.
Main Methods:
- Literature review of studies on EETs, diabetes, and cardiovascular disease.
- Analysis of animal models and experimental evidence regarding sEH inhibitors.
Main Results:
- EETs are vital signaling molecules promoting vasodilation, anti-inflammation, and insulin sensitivity.
- Decreased EET availability is observed in diabetes models, contributing to organ damage.
- sEH inhibitors show promise in preventing endothelial dysfunction and organ damage in metabolic diseases.
Conclusions:
- The EET pathway is disrupted in early metabolic diseases, impairing endothelial function and driving diabetic cardiovascular complications.
- Further research is needed to confirm EET pathway alterations in human diabetic endothelial dysfunction.
- sEH inhibitors represent a promising therapeutic strategy to prevent diabetic cardiovascular complications and improve patient outcomes.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...